Why less cancer patients are dying in US hospitals than others

By Admin
According to a new international study by the Journal of American Medical Association (JAMA), fewer cancer patients are dying in United States hospitals...

According to a new international study by the Journal of American Medical Association (JAMA), fewer cancer patients are dying in United States hospitals than other developed countries.

In 2010, 22.2 percent of cancer patients in the U.S. died in the hospital compared to 70 percent in the 1980s. It is the lowest rate of the countries in the study, which includes Belgium, Canada, England, Germany, the Netherlands and Norway.

RELATED TOPIC: Q&A with Michael Suba: The businessman using philanthropy to stand up against cancer

The international Consortium for End-of-Life Research systematically examined patterns of care, healthcare utilization and expenditures in senior patients older than 65 who died from cancer in hospitals in 2010.

“The essential take-away from the study is that there is great variability across the nations in end-of-life practices, but we know now that we can reduce the intensity of care at the end of life in the U.S. and in other nations, and we know we need to move end-of-life care out of hospitals,” said University of Pennsylvania MD Justin Bekelman.

RELATED TOPIC: Rising cancer drug costs lead to doctor protests against Big Pharma

“We know that end-of-life care is expensive, intensive and not consistent with the wishes of our patients, and we also know that too many patients are still dying in the hospital in the U.S., but what we didn’t know is how the U.S. compares with other countries.”

In addition, the study also reveals American patients who do indeed pass away while in the hospital spend fewer days there during the final six months of their lives.

RELATED TOPIC: How Elekta is providing state-of-the-art cancer treatment to patients in Namibia

However, more than twice as many U.S. patients who pass away from cancer are admitted to the intensive care unit (ICU) and receive more chemotherapy in the final six months of their lives.

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

 

 

Share

Featured Articles

Grifols & Orange Business Launch Egypt Plasma Project

Grifols & Orange Business Complete landmark phase of Data Centre for Plasma Derivatives Facility, designed to boost healthcare in Egypt

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Medical Devices & Pharma

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain